Inhibition of proliferation of retinal vascular endothelial cells more effectively than choroidal vascular endothelial cell proliferation by bevacizumab
Author(s) -
Bharani K Mynampati,
Kumar Sambhav,
Sandeep Grover,
K V Chalam
Publication year - 2017
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2017.01.03
Subject(s) - trypan blue , medicine , bevacizumab , vascular endothelial growth factor , cell growth , retinal , viability assay , ophthalmology , microbiology and biotechnology , endothelial stem cell , vascular endothelial growth factor a , andrology , cell , pathology , in vitro , vegf receptors , biology , chemotherapy , biochemistry
To evaluate the differential inhibitory effects of bevacizumab on cell proliferation of vascular endothelial growth factor (VEGF)-stimulated choroidal vascular endothelial cells (CVECs) and retinal vascular endothelial cells (RVECs) in vitro.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom